Patent 7786164 was granted and assigned to Sonus Pharmaceuticals Inc. on August, 2010 by the United States Patent and Trademark Office.
Lipophilic di(anticancer drug) compounds, compositions that include the compounds, and methods for treating a cell proliferative disease using the compounds.